Definitive Outcomes Of Radiofrequency Ablation For Barrett’s Esophagus Using The HALO Ablation System Reported At The Digestive Disease Week

Results from a number of clinical trials were presented during the Digestive Disease Week (DDW) in Chicago this week, revealing new outcomes data related to endoscopic radiofrequency ablation using the HALO ablation system for eradicating a pre-cancerous esophageal condition known as Barrett’s esophagus. Among them, reports included durability outcomes from a randomized sham-controlled trial, safety and efficacy outcomes from a large U.S.

More: continued here

Filed under: Clinical Trials on June 5th, 2009